In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CVS aims to change health care delivery in $77bn acquisition of Aetna

Executive Summary

In a move to streamline and improve health care delivery, retail pharmacy giant and pharmaceutical benefits manager (PBM) CVS Health Corp. signed a definite agreement to buy publicly traded insurance company Aetna Inc. CVS is spending $145 in cash and issuing 0.8378 in its shares for each Aetna share, which is valued at $206 (a 16% premium). The entire agreement is worth $77bn, including the assumption of Aetna's debt. Upon deal closing, CVS stockholders will own 78% of the combined entity, and Aetna the rest.
Deal Industry
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies